Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (−) enantiomer
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 168 (3), 912-916
- https://doi.org/10.1016/0006-291x(90)91115-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosidesJournal of Medicinal Chemistry, 1990
- Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridineJournal of Medicinal Chemistry, 1989
- Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerasesBiochemical and Biophysical Research Communications, 1989
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- Liquid chromatographic assay of carbovir, a carbocyclic nucleoside active against human immunodeficiency virusJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitroBiochemical and Biophysical Research Communications, 1988
- Resolution of racemic carbocyclic analogs of purine nucleosides through the action of adenosine deaminase. Antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomersJournal of Medicinal Chemistry, 1987
- Resolution of aristeromycin enantiomersJournal of Medicinal Chemistry, 1985